Chronic conditions
Cost control
Pharmacy
GLP-1s, specialty spend, and a 9% cost surge
Healthcare costs are projected to rise 9%. Dr. Nirav Vakharia explains why strengthening primary care, not restricting GLP-1s, is the smarter cost-control strategy.